DE2127159C2 - IgG-Immunglobulinfraktion und ihre Herstellung - Google Patents

IgG-Immunglobulinfraktion und ihre Herstellung

Info

Publication number
DE2127159C2
DE2127159C2 DE19712127159 DE2127159A DE2127159C2 DE 2127159 C2 DE2127159 C2 DE 2127159C2 DE 19712127159 DE19712127159 DE 19712127159 DE 2127159 A DE2127159 A DE 2127159A DE 2127159 C2 DE2127159 C2 DE 2127159C2
Authority
DE
Germany
Prior art keywords
solution
igg
blood
plasma
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19712127159
Other languages
German (de)
English (en)
Other versions
DE2127159A1 (de
Inventor
Lars-Gunnar Stockholm Albinsson Falksveden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Original Assignee
STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE filed Critical STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Publication of DE2127159A1 publication Critical patent/DE2127159A1/de
Application granted granted Critical
Publication of DE2127159C2 publication Critical patent/DE2127159C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19712127159 1970-06-02 1971-06-01 IgG-Immunglobulinfraktion und ihre Herstellung Expired DE2127159C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (enExample) 1970-06-02 1970-06-02

Publications (2)

Publication Number Publication Date
DE2127159A1 DE2127159A1 (de) 1971-12-09
DE2127159C2 true DE2127159C2 (de) 1981-12-24

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712127159 Expired DE2127159C2 (de) 1970-06-02 1971-06-01 IgG-Immunglobulinfraktion und ihre Herstellung

Country Status (8)

Country Link
AT (1) AT309678B (enExample)
CA (1) CA960964A (enExample)
CH (1) CH572745A5 (enExample)
DE (1) DE2127159C2 (enExample)
FR (1) FR2100716B1 (enExample)
GB (1) GB1344340A (enExample)
NL (1) NL177599C (enExample)
SE (1) SE348942B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2751717A1 (de) * 1976-12-03 1978-07-13 Myer Louis Dr Coval Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
EP2376523A4 (en) * 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab PRECIPITATION OF BIOMOLECULES USING NEGATIVELY LOADED POLYMERS
BRPI1012082B1 (pt) 2009-05-27 2022-08-16 Takeda Pharmaceutical Company Limited Método para preparar uma composição de igg concentrada a partir de plasma
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
MX349005B (es) 2011-08-26 2017-07-06 Baxalta Inc Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
EA201892521A1 (ru) 2012-02-29 2019-07-31 Баксалта Инкорпорейтид РЕМИЕЛИНИЗАЦИЯ ПЕРИФЕРИЧЕСКИХ НЕРВОВ, СТИМУЛИРОВАННАЯ IgG
DK2961426T3 (da) 2013-02-26 2019-12-02 Baxalta GmbH Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g
EP2994160B1 (en) 2013-05-06 2019-07-03 Baxalta Incorporated Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
WO2023170553A1 (en) 2022-03-07 2023-09-14 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (enExample) * 1962-01-03
BE713764A (enExample) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2751717A1 (de) * 1976-12-03 1978-07-13 Myer Louis Dr Coval Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AT309678B (de) 1973-08-27
FR2100716A1 (enExample) 1972-03-24
DE2127159A1 (de) 1971-12-09
NL7107529A (enExample) 1971-12-06
FR2100716B1 (enExample) 1975-06-06
CH572745A5 (enExample) 1976-02-27
NL177599C (nl) 1985-10-16
NL177599B (nl) 1985-05-17
SE348942B (enExample) 1972-09-18
GB1344340A (en) 1974-01-23
CA960964A (en) 1975-01-14

Similar Documents

Publication Publication Date Title
DE2127159C2 (de) IgG-Immunglobulinfraktion und ihre Herstellung
DE2645466C2 (de) Verfahren zum Isolieren von Albumin aus Plasmaprodukten
EP0013901B1 (de) Verfahren zur Herstellung einer für die intravenöse Applikation geeigneten Immunglobulinlösung, die IgM in ankonzentrierter Form enthält
DE60102144T2 (de) EINE METHODE ZUR HERSTELLUNG VON IgG
DE69127657T2 (de) Proteinreinigungsmethode
DE2430356C2 (enExample)
DE2801123C2 (de) Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
CH634334A5 (de) Neues glycoprotein und verfahren zu dessen herstellung.
EP0000134B1 (de) Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum
DE3218348A1 (de) Verfahren zur extraktion von proteinen, insbesondere von lactoferrin und immunglobulinen aus milch
DE3927111A1 (de) Nicht modifizierte intravenoes verabreichbare igm- und/oder iga-haltige immunglobulinpraeparate und verfahren zu ihrer herstellung
EP0060491A2 (de) Protein (PP16), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0009715A1 (de) Neues ubiquitäres Gewebsprotein PP8 und Verfahren zu seiner Anreicherung
EP0033000A1 (de) Neues Protein PP15, ein Verfahren zu seiner Herstellung sowie seine Verwendung
DE2742150C2 (enExample)
DE10029705A1 (de) Herstellung von IgY(AFc)-Antikörpern und deren Verwendung
DE1617805C3 (de) Verfahren zur Gewinnung von Lysozym aus Eiweiß
DE2732998A1 (de) Verfahren zur herstellung von serumalbumin
DE69030414T2 (de) Reinigung von Albumin
CH632091A5 (en) Process for the preparation of an antiserum directed against placenta-specific glycoprotein
EP0035726B1 (de) Verfahren und diagnostisches Mittel zur direkten Bestimmung des Lipidgehaltes der beta-Lipoproteine des Blutes
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
EP0156266A2 (de) Gewebeprotein PP21, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE10065227A1 (de) Verfahren zur Isolierung und Reinigung von Eigelb-Antikörpern aus Vogeleiweiß und Verwendung von dadurch erhaltenen Eigelb-Antikörpern
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination